Seeing Is Believing
Health Care Equipment & Supplies - Industry
Intersect ENT's activity chart (see below) currently has 75 price targets and 56 ratings on display.
Analysts average stock forecasts to be materialized ratio is 74.06% with an average time for these price targets to be met of 161.65 days.
Most recent stock forecast was given by from TRUIST on 11-Aug-2021. First documented stock forecast 18-Aug-2014.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 11-Aug-2021
$28.25
$0.01 (0.04%)
$23
5 years 1 months 24 days ago
(11-Aug-2021)
11/13 (84.62%)
$0.67 (2.43%)
119
Buy Since 09-Aug-2021
$28
$-0.24 (-0.85%)
$30
5 years 1 months 26 days ago
(09-Aug-2021)
1/2 (50%)
$0.17 (0.61%)
1
Buy Since 25-Jan-2021
$28.25
5 years 1 months 26 days ago
(09-Aug-2021)
1/8 (12.5%)
$0.88 (3.22%)
2
Hold Since 22-Oct-2020
$23
5 years 4 months 17 days ago
(18-May-2021)
4/4 (100%)
$0.84 (3.79%)
41
Hold Since 15-Oct-2020
$17
$-11.24 (-39.80%)
$17
5 years 11 months 20 days ago
(15-Oct-2020)
14/17 (82.35%)
$-0.7 (-3.95%)
99
What is XENT (Intersect ENT) average time for price targets to be met?
Which analyst most recently updated their price target on XENT (Intersect ENT)?
Which analyst has the most public recommendations on XENT (Intersect ENT)?
Which analyst is the currently most bullish on XENT (Intersect ENT)?
Which analyst is the currently most reserved on XENT (Intersect ENT)?